Sato Vicki L

Sato Vicki L is listed in filings as Director at Vir Biotechnology, Inc.. This profile follows SEC Form 4 activity through May 4, 2026, including sale activity. Recent filings connect the profile to Vir Biotechnology, Inc. (VIR), Allogene Therapeutics, Inc. (ALLO), and Denali Therapeutics Inc. (DNLI). The current snapshot covers public activity from Jul 3, 2024 to May 4, 2026. Reported amounts are shown as $221.0K to $207.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.